GenSight Biologics S.A. (GSGTF)
OTCMKTS · Delayed Price · Currency is USD
0.2400
-0.0800 (-25.00%)
At close: Dec 31, 2024

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Novel Therapies for Mitochondrial and Neurodegenerative Disease
1.27M
Log In
Log In
Log In
Log In
Novel Therapies for Mitochondrial and Neurodegenerative Disease Growth
-50.93%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
France
1.27M
Log In
Log In
Log In
Log In
France Growth
-50.93%
Log In
Log In
Log In
Log In